Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-20-036666

Options or other derivatives

  • Director acquired 14,210 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mathers Edward T · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-11 Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) +14,210 14,210 D
Loading xslF345X03/doc4.xml…